Fundraising Fox
Bostoncellstandards
Boston, US · 1 known investors
Find your way into Bostoncellstandards
Each arrow is one introduction. Sign up to fill in the first one.
Ask Rosanne Welcher to introduce you to Seshi Sompuram
You →Rosanne · together at Dako →Seshi
Sign up to find every way you can get introduced to Bostoncellstandards
- Your email: who you already know at Bostoncellstandards, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Bostoncellstandards team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Boston Cell Standards develops calibration and quality-control products (IHCalibrators and IHControls) for immunohistochemistry (IHC) laboratories, used for assay validation, instrument alignment, troubleshooting, and proficiency testing. Its standards serve clinical and research labs and drug developers to maintain consistent IHC test results across sites and trial phases for accurate patient diagnosis and treatment stratification.
Founders & leadership
Investors · 1
How we know: the VCSheet dataset · Not right? Tell us
Non-dilutive funding · 12 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $385.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $219.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $301.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $228.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $145.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2007 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2006 | $1.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2004 | $863.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $225.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Bostoncellstandards do?
- Boston Cell Standards develops calibration and quality-control products (IHCalibrators and IHControls) for immunohistochemistry (IHC) laboratories, used for assay validation, instrument alignment, troubleshooting, and proficiency testing. Its standards serve clinical and research labs and drug developers to maintain consistent IHC test results across sites and trial phases for accurate patient diagnosis and treatment stratification.
- Who founded Bostoncellstandards?
- Bostoncellstandards was founded by Steve Bogen MD PhD, Kodela Vani, MS, Seshi Sompuram.
- Who are Bostoncellstandards's investors?
- Bostoncellstandards's investors include Bantam Group.
- Where is Bostoncellstandards headquartered?
- Bostoncellstandards is headquartered in Boston, US.